FOXO1 and metabolic dysfunction-associated steatohepatitis: In addition, FOXO1 expression differs in precancerous lesions from two conditions that lead to HCC, non-alcoholic steatohepatitis (NASH) and alcoholic steatohepatitis (ASH), which also reflects different tumorigenic rates for ASH and NASH (137).